← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

CROX logoCrocs, Inc.(CROX)Earnings, Financials & Key Ratios

CROX•NASDAQ
$105.75
$5.29B mkt cap·Price updated May 6, 2026
SectorConsumer CyclicalIndustryFootwear & AccessoriesSub-IndustryAthletic and casual footwear brands
AboutCrocs, Inc., together with its subsidiaries, designs, develops, manufactures, markets, and distributes casual lifestyle footwear and accessories for men, women, and children. It offers various footwear products, including clogs, sandals, slides, flip-flops, boots, flats, wedges, platforms, socks, shoe charms, loafers, sneakers, and slippers under the Crocs brand name. The company sells its products in approximately 85 countries through wholesalers, retail stores, e-commerce sites, and third-party marketplaces. As of December 31, 2021, it had 193 outlet stores, 107 retail stores, 373 company-operated stores, 73 kiosks and store-in-stores, and 14 company-operated e-commerce sites. The company serves in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. Crocs, Inc. was founded in 1999 and is headquartered in Broomfield, Colorado.Show more
  • Revenue$4.04B-1.5%
  • EBITDA$967M-11.4%
  • Net Income-$81M-108.5%
  • EPS (Diluted)-1.50-109.4%
  • Gross Margin56.97%-3.0%
  • EBITDA Margin23.93%-10.1%
  • Operating Margin21.97%-11.8%
  • Net Margin-2.01%-108.7%
  • ROE-5.19%-109.0%
  • ROIC21.71%-5.7%
  • Debt/Equity1.25+34.6%
  • Interest Coverage10.05+7.7%
Technical→

CROX Key Insights

Crocs, Inc. (CROX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Excellent 3Y average ROE of 40.8%
  • ✓FCF machine: 16.3% free cash flow margin
  • ✓Strong 5Y sales CAGR of 23.9%
  • ✓Share count reduced 9.4% through buybacks
  • ✓Healthy 5Y average net margin of 17.5%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CROX Price & Volume

Crocs, Inc. (CROX) stock price & volume — 10-year historical chart

Loading chart...

CROX Growth Metrics

Crocs, Inc. (CROX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years13.99%
5 Years23.86%
3 Years4.36%
TTM-1.85%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-110.83%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-108.46%

Return on Capital

10 Years26.65%
5 Years35.72%
3 Years25.28%
Last Year23.52%

CROX Recent Earnings

Crocs, Inc. (CROX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Apr 30, 2026
EPS
$2.99
Est $2.78
+7.6%
Revenue
$921M
Est $901M
+2.3%
Q1 2026
Feb 12, 2026
EPS
$2.29
Est $1.92
+19.3%
Revenue
$958M
Est $917M
+4.4%
Q4 2025
Oct 30, 2025
EPS
$2.92
Est $2.36
+23.7%
Revenue
$996M
Est $960M
+3.8%
Q3 2025
Aug 7, 2025
EPS
$4.23
Est $4.01
+5.5%
Revenue
$1.1B
Est $1.0B
+14.0%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 30, 2026
$2.99vs $2.78+7.6%
$921Mvs $901M+2.3%
Q1 2026Feb 12, 2026
$2.29vs $1.92+19.3%
$958Mvs $917M+4.4%
Q4 2025Oct 30, 2025
$2.92vs $2.36+23.7%
$996Mvs $960M+3.8%
Q3 2025Aug 7, 2025
$4.23vs $4.01+5.5%
$1.1Bvs $1.0B+14.0%
Based on last 12 quarters of dataView full earnings history →

CROX Peer Comparison

Crocs, Inc. (CROX) competitors in Athletic and casual footwear brands — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
DECK logoDECKDeckers Outdoor CorporationDirect Competitor14.79B103.9216.4216.28%19.35%39.85%0.11
SHOO logoSHOOSteven Madden, Ltd.Direct Competitor2.92B40.0263.5210.45%2.89%8.45%0.54
WWW logoWWWWolverine World Wide, Inc.Direct Competitor1.41B17.250.196.8%5.06%17.68%1.22
CAL logoCALCaleres, Inc.Direct Competitor453.7M13.49-61.321.29%-0.26%-1.14%0.77
NKE logoNKENIKE, Inc.Product Competitor52.26B43.8820.31-9.84%5.43%17.92%0.83
UAA logoUAAUnder Armour, Inc.Product Competitor1.31B6.46-13.75-9.43%-10.44%-36.22%0.69
COLM logoCOLMColumbia Sportswear CompanyProduct Competitor3.32B63.4519.580.84%4.98%10.26%0.51
BOOT logoBOOTBoot Barn Holdings, Inc.Product Competitor5.23B171.9029.2314.64%8.91%14.16%0.50

Compare CROX vs Peers

Crocs, Inc. (CROX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DECK

Most directly comparable listed peer for CROX.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare CROX against a more recognizable public peer.

Peer Set

Compare Top 5

vs DECK, SHOO, WWW, CAL

CROX Income Statement

Crocs, Inc. (CROX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue1.02B1.09B1.23B1.39B2.31B3.55B3.96B4.1B4.04B4.02B
Revenue Growth %-1.23%6.32%13.08%12.62%66.92%53.67%11.46%3.53%-1.5%-1.85%
Cost of Goods Sold506.29M528.05M613.54M636M893.2M1.69B1.78B1.69B1.74B1.69B
COGS % of Revenue49.47%48.52%49.86%45.89%38.61%47.67%45.04%41.24%43.03%-
Gross Profit
517.22M▲ 0%
560.15M▲ 8.3%
617.06M▲ 10.2%
749.95M▲ 21.5%
1.42B▲ 89.4%
1.86B▲ 31.0%
2.18B▲ 17.1%
2.41B▲ 10.7%
2.3B▼ 4.5%
2.34B▲ 0%
Gross Margin %50.53%51.48%50.14%54.11%61.39%52.33%54.96%58.76%56.97%58.1%
Gross Profit Growth %3.41%8.3%10.16%21.54%89.38%30.99%17.06%10.68%-4.5%-
Operating Expenses494.6M497.21M488.41M535.82M737.16M1.01B1.13B1.39B1.41B1.47B
OpEx % of Revenue48.32%45.69%39.69%38.66%31.86%28.4%28.55%33.84%35%-
Selling, General & Admin494.6M447.78M457.63M535.82M715.89M929.16M1.11B1.29B1.38B1.47B
SG&A % of Revenue48.32%41.15%37.19%38.66%30.95%26.14%28.01%31.47%34.27%-
Research & Development00010.2M13.7M18.7M21.4M25.6M29.6M0
R&D % of Revenue---0.74%0.59%0.53%0.54%0.62%0.73%-
Other Operating Expenses-13.4M35.33M18.97M-10.2M7.56M61.67M071.85M00
Operating Income
17.34M▲ 0%
62.94M▲ 263.1%
128.65M▲ 104.4%
214.12M▲ 66.4%
683.06M▲ 219.0%
850.76M▲ 24.5%
1.05B▲ 23.0%
1.02B▼ 2.3%
887.63M▼ 13.1%
865.5M▲ 0%
Operating Margin %1.69%5.78%10.45%15.45%29.53%23.93%26.41%24.91%21.97%21.5%
Operating Income Growth %381.7%263.08%104.39%66.44%219%24.55%23%-2.35%-13.14%-
EBITDA50.47M92.19M152.86M241.74M715.04M889.99M1.1B1.09B966.91M946.49M
EBITDA Margin %4.93%8.47%12.42%17.44%30.91%25.03%27.78%26.61%23.93%23.52%
EBITDA Growth %80.95%82.69%65.8%58.14%195.79%24.47%23.68%-0.82%-11.43%-13.22%
D&A (Non-Cash Add-back)33.13M29.25M24.21M27.62M31.98M39.23M54.3M69.84M79.28M80.98M
EBIT19.05M66.11M127.96M213.72M685.5M854.67M1.04B1.02B887.63M865.5M
Net Interest Income1K326K-8.04M-6.53M-20.87M-135.14M-158.94M-105.78M-86.44M-84.13M
Interest Income870K1.28M601K215K775K1.02M2.41M3.48M1.84M1.85M
Interest Expense869K955K8.64M6.74M21.65M136.16M161.35M109.26M88.29M85.98M
Other Income/Expense844K2.21M-9.33M-7.14M-19.21M-132.25M-170.2M-111.33M-814.65M-818.62M
Pretax Income
18.18M▲ 0%
65.16M▲ 258.4%
119.32M▲ 83.1%
206.98M▲ 73.5%
663.85M▲ 220.7%
718.51M▲ 8.2%
876.27M▲ 22.0%
910.59M▲ 3.9%
72.98M▼ 92.0%
46.88M▲ 0%
Pretax Margin %1.78%5.99%9.7%14.93%28.7%20.21%22.12%22.2%1.81%1.16%
Income Tax7.94M14.72M-175K-105.88M-61.84M178.35M83.71M-39.49M154.18M150.63M
Effective Tax Rate %43.69%22.59%-0.15%-51.16%-9.32%24.82%9.55%-4.34%211.26%321.28%
Net Income
10.24M▲ 0%
50.44M▲ 392.6%
119.5M▲ 136.9%
312.86M▲ 161.8%
725.69M▲ 132.0%
540.16M▼ 25.6%
792.57M▲ 46.7%
950.07M▲ 19.9%
-81.2M▼ 108.5%
-103.75M▲ 0%
Net Margin %1%4.63%9.71%22.57%31.37%15.19%20%23.16%-2.01%-2.58%
Net Income Growth %162.07%392.64%136.92%161.81%131.95%-25.57%46.73%19.87%-108.55%-110.83%
Net Income (Continuing)10.24M50.44M119.5M312.86M725.69M540.16M792.57M950.07M-81.2M-103.75M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)
-0.07▲ 0%
-1.01▼ 1342.9%
1.67▲ 265.3%
4.56▲ 173.1%
11.39▲ 149.8%
8.71▼ 23.5%
12.79▲ 46.8%
15.88▲ 24.2%
-1.50▼ 109.4%
-2.05▲ 0%
EPS Growth %83.72%-1342.86%265.35%173.05%149.78%-23.53%46.84%24.16%-109.45%-108.46%
EPS (Basic)-0.07-1.011.704.6411.628.8212.9116.00-1.50-
Diluted Shares Outstanding72.25M68.42M71.77M68.54M63.72M62.01M61.95M59.83M54.21M50.71M
Basic Shares Outstanding72.25M68.42M70.36M67.39M62.46M61.22M61.39M59.38M54.21M50.28M
Dividend Payout Ratio----------

CROX Balance Sheet

Crocs, Inc. (CROX) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets425.05M380.3M425.38M492.84M666.57M1.03B910.7M872.27M885.88M1.07B
Cash & Short-Term Investments174.27M125.31M109.75M137.34M213.26M191.63M149.29M180.49M130.35M130.88M
Cash Only174.27M125.31M109.75M137.34M213.26M191.63M149.29M180.49M130.35M130.88M
Short-Term Investments0000000000
Accounts Receivable97.83M108.37M118.25M162.52M217.18M329.19M331.23M283.91M333.06M470.08M
Days Sales Outstanding34.8936.3535.0742.834.2733.830.5125.2630.0936.46
Inventory130.35M124.49M172.03M175.12M213.52M471.55M385.05M356.25M368.69M397.56M
Days Inventory Outstanding93.9786.05102.34100.587.25101.5678.7576.8677.3984.87
Other Current Assets2.14M1.95M1.5M1.54M65K33.61M45.13M51.62M53.79M66.69M
Total Non-Current Assets118.65M88.6M313.42M625.88M878.5M3.48B3.73B3.94B3.29B3.28B
Property, Plant & Equipment35.03M22.21M229.63M224.89M269.17M421.43M525.75M551.56M576.86M582.01M
Fixed Asset Turnover29.22x48.99x5.36x6.16x8.59x8.44x7.54x7.44x7.00x6.87x
Goodwill1.69M1.61M1.58M1.72M1.6M714.81M711.59M711.49M404.69M404.66M
Intangible Assets56.43M45.69M47.09M37.64M28.8M1.8B1.79B1.78B1.32B1.32B
Long-Term Investments2.78M2.22M2.29M1.93M3.66M3.25M3.81M3.19M010.59M
Other Non-Current Assets12.54M8.21M8.07M8.93M8.07M7.87M31.45M24.21M47.58M169.77M
Total Assets
543.7M▲ 0%
468.9M▼ 13.8%
738.8M▲ 57.6%
1.12B▲ 51.4%
1.55B▲ 38.1%
4.5B▲ 191.4%
4.64B▲ 3.2%
4.81B▲ 3.6%
4.17B▼ 13.2%
4.34B▲ 0%
Asset Turnover1.88x2.32x1.67x1.24x1.50x0.79x0.85x0.85x0.97x0.93x
Asset Growth %-4.01%-13.76%57.56%51.42%38.11%191.37%3.16%3.62%-13.25%-41.99%
Total Current Liabilities157.02M184.49M257.22M291.58M388.24M641.27M698.3M740.21M700.13M639.52M
Accounts Payable66.38M77.23M95.75M112.78M162.15M230.82M260.98M264.9M266.09M242.47M
Days Payables Outstanding47.8653.3856.9764.7266.2649.7153.3757.1555.8653.53
Short-Term Debt676K048.59M47.06M42.93M81.82M85.59M68.55M093.85M
Deferred Revenue (Current)0000100K6.8M0000
Other Current Liabilities49.49M58.2M66.22M77.83M103.84M177.15M215.53M216.8M184.84M259.43M
Current Ratio2.71x2.06x1.65x1.69x1.72x1.60x1.30x1.18x1.27x1.27x
Quick Ratio1.88x1.39x0.98x1.09x1.17x0.86x0.75x0.70x0.74x0.74x
Cash Conversion Cycle8169.0280.4578.5855.2685.6555.8944.9751.6267.81
Total Non-Current Liabilities18.38M134.1M349.67M536.51M1.14B3.04B2.49B2.24B2.18B2.28B
Long-Term Debt0120M205M180M771.39M2.3B1.64B1.35B1.23B1.33B
Capital Lease Obligations00140.15M146.4M149.24M215.12M269.77M283.41M297.19M1.21B
Deferred Tax Liabilities0000176K302.03M12.91M4.09M882K3.96M
Other Non-Current Liabilities18.35M14.1M4.53M210.1M222.12M227.42M567.94M599.38M653.26M2.54B
Total Liabilities175.4M318.59M606.9M828.09M1.53B3.68B3.19B2.98B2.88B2.92B
Total Debt676K120M393.73M373.46M963.56M2.59B2B1.7B1.61B395.17M
Net Debt-173.57M-5.31M283.98M236.12M750.3M2.4B1.85B1.52B1.48B264.29M
Debt / Equity0.00x0.80x2.98x1.29x68.42x3.17x1.37x0.93x1.25x1.25x
Debt / EBITDA0.01x1.30x2.58x1.54x1.35x2.92x1.81x1.56x1.67x0.42x
Net Debt / EBITDA-3.44x-0.06x1.86x0.98x1.05x2.70x1.68x1.39x1.53x1.53x
Interest Coverage21.92x69.23x14.82x31.70x31.67x6.28x6.43x9.33x10.05x10.07x
Total Equity
368.3M▲ 0%
150.31M▼ 59.2%
131.91M▼ 12.2%
290.63M▲ 120.3%
14.08M▼ 95.2%
817.93M▲ 5708.3%
1.45B▲ 77.8%
1.84B▲ 26.3%
1.29B▼ 29.5%
1.43B▲ 0%
Equity Growth %-7.76%-59.19%-12.24%120.34%-95.15%5708.34%77.76%26.26%-29.55%-92.1%
Book Value per Share5.102.201.844.240.2213.1923.4730.6823.8628.15
Total Shareholders' Equity368.3M150.31M131.91M290.63M14.08M817.93M1.45B1.84B1.29B1.43B
Common Stock95K103K104K105K106K110K110K110K111K111K
Retained Earnings190.43M121.22M240.49M553.35M1.28B1.82B2.61B3.56B3.48B3.62B
Treasury Stock-334.31M-397.49M-546.21M-688.85M-1.68B-1.7B-1.89B-2.45B-3.04B-3.04B
Accumulated OCI-43.39M-54.65M-58.38M-56.35M-76.84M-103.49M-95.77M-132.65M-43.66M-55.44M
Minority Interest0000000000

CROX Cash Flow Statement

Crocs, Inc. (CROX) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations98.26M114.16M89.96M266.9M567.16M603.14M930.44M992.49M710.43M710.43M
Operating CF Margin %9.6%10.49%7.31%19.26%24.52%16.97%23.48%24.19%17.58%-
Operating CF Growth %147.18%16.18%-21.2%196.7%112.5%6.34%54.27%6.67%-28.42%-48.76%
Net Income10.24M50.44M119.5M312.86M725.69M540.16M792.57M950.07M105.17M-103.75M
Depreciation & Amortization33.13M29.25M24.21M27.62M31.98M39.23M54.3M69.84M79.28M80.98M
Stock-Based Compensation9.77M13.11M14.41M16.36M38.12M31.3M29.07M33.05M36.7M38.53M
Deferred Taxes-3.09M959K-16.26M-325.06M-241.28M-4.76M-410.32M-254.45M47.09M4.42M
Other Non-Cash Items3.31M8.45M59.39M102.73M57.18M88.89M98.3M125.55M589.29M898.04M
Working Capital Changes44.9M11.96M-111.3M132.39M-44.53M-91.68M366.52M68.43M-147.1M-193.71M
Change in Receivables620K-24.62M-15.02M-47.05M-35.06M-56.77M-13.32M42.59M-6.17M11.98M
Change in Inventory23.32M-1.99M-48.16M-13.46M-43.06M-91.61M86.35M22.05M-13.84M-8.17M
Change in Payables-2.71M12.95M6.03M23.23M34.87M41.7M37.2M3.95M709K2.63M
Cash from Investing-11.54M-10.11M-36.24M-41.76M-55.92M-2.15B-115.67M-69.35M-51.23M-53.86M
Capital Expenditures-13.12M-11.98M-36.58M-42.03M-55.92M-104.19M-115.63M-69.35M-51.23M-53.86M
CapEx % of Revenue1.28%1.1%2.97%3.03%2.42%2.93%2.92%1.69%1.27%-
Acquisitions000463K6K-2.05B0000
Investments----------
Other Investing1.58M1.87M340K-192K-15K-20K-46K000
Cash from Financing-65.37M-148.8M-68.64M-198.04M-429.64M1.53B-859.64M-886.05M-714.57M-708.08M
Debt Issued (Net)-3.11M119.34M85M-25M605M1.59B-665.8M-323.25M-128M-183.24M
Equity Issued (Net)-50M-246.85M-148.72M-173.89M-1.02B-11.48M-192.1M-560.69M-586.57M-523.91M
Dividends Paid-12M-21.02M-2.98M0000000
Share Repurchases-50M-246.85M-148.72M-173.89M-1.02B-11.48M-192.1M-560.69M-586.57M-523.91M
Other Financing-259K-270K-1.94M854K-14.52M-53.48M-1.74M-2.11M0-935K
Net Change in Cash
24.56M▲ 0%
-49.52M▼ 301.6%
-15.48M▲ 68.7%
27.23M▲ 275.8%
77.65M▲ 185.2%
-22.04M▼ 128.4%
-41.79M▼ 89.6%
30.58M▲ 173.2%
-49.77M▼ 262.7%
-35.58M▲ 0%
Free Cash Flow
85.15M▲ 0%
102.18M▲ 20.0%
53.38M▼ 47.8%
224.87M▲ 321.2%
511.25M▲ 127.4%
498.95M▼ 2.4%
814.82M▲ 63.3%
923.14M▲ 13.3%
659.2M▼ 28.6%
670.66M▲ 0%
FCF Margin %8.32%9.39%4.34%16.22%22.1%14.04%20.56%22.5%16.31%16.66%
FCF Growth %384.89%20.01%-47.76%321.25%127.35%-2.41%63.31%13.29%-28.59%-24.12%
FCF per Share1.181.490.743.288.028.0513.1515.4312.1612.16
FCF Conversion (FCF/Net Income)9.60x2.26x0.75x0.85x0.78x1.12x1.17x1.04x-8.75x-6.46x
Interest Paid434K462K7.52M6.66M10.21M127.81M151.62M99.46M039.03M
Taxes Paid13.21M18.63M16.05M20.82M159.68M130.08M179.72M124.96M0114.23M

CROX Key Ratios

Crocs, Inc. (CROX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)2.67%19.45%84.69%148.09%476.31%129.84%69.77%57.76%-5.19%-7.54%
Return on Invested Capital (ROIC)5.83%27.79%34.41%34.07%79.36%32.02%24.07%23.02%21.71%21.71%
Gross Margin50.53%51.48%50.14%54.11%61.39%52.33%54.96%58.76%56.97%58.1%
Net Margin1%4.63%9.71%22.57%31.37%15.19%20%23.16%-2.01%-2.58%
Debt / Equity0.00x0.80x2.98x1.29x68.42x3.17x1.37x0.93x1.25x1.25x
Interest Coverage21.92x69.23x14.82x31.70x31.67x6.28x6.43x9.33x10.05x10.07x
FCF Conversion9.60x2.26x0.75x0.85x0.78x1.12x1.17x1.04x-8.75x-6.46x
Revenue Growth-1.23%6.32%13.08%12.62%66.92%53.67%11.46%3.53%-1.5%-1.85%

CROX SEC Filings & Documents

Crocs, Inc. (CROX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Feb 12, 2026·SEC

Material company update

Oct 30, 2025·SEC

10-K Annual Reports

3
FY 2026

Feb 12, 2026·SEC

FY 2025

Feb 13, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 30, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Aug 7, 2025·SEC

CROX Frequently Asked Questions

Crocs, Inc. (CROX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Crocs, Inc. (CROX) reported $4.02B in revenue for fiscal year 2025. This represents a 345374% increase from $1.2M in 2003.

Crocs, Inc. (CROX) saw revenue decline by 1.5% over the past year.

Crocs, Inc. (CROX) reported a net loss of $103.7M for fiscal year 2025.

Dividend & Returns

Crocs, Inc. (CROX) has a return on equity (ROE) of -5.2%. Negative ROE indicates the company is unprofitable.

Crocs, Inc. (CROX) generated $670.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More CROX

Crocs, Inc. (CROX) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.